Portfolio
Management

Shrinking pipelines, lack of innovative ideas, increased cost of therapy development, regulatory pressures, reimbursement issues, and stagnation in revenue through previous innovative therapy sales- these are some of the major issues plaguing the Pharma sector and are also reasons which are forcing these companies to rethink their clinical developmental strategy to meet corporate goals.

• There is an issue in not being able to understand which areas of focus might or might not align with the vision of the company, depleting valuable resources of the company that could otherwise be utilized on something that may prove to be beneficial in the future.
• A major aspect to be considered here is to understand one’s core competencies, assess the assets and products that can be managed with those core competencies and then understand the bounds of one’s developmental and commercial aspects.
• Portfolio management not only includes assessment of products whose development might be beneficial for company’s future growth, but also aligns the competencies of the company with the vision of the company, creating a positive organizational culture and potent workforce.